Bullboard - Stock Discussion Forum Liminal BioSciences Inc. LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed... see more

Add To Watchlist

NDAQ:LMNL - Post Discussion

Liminal BioSciences Inc. > Any covid opportunities

View:

Post by NoobInvest69 on Apr 30, 2020 1:12pm

Any covid opportunities

The FDA is currently encouraging patients who have recovered from Covid-19 to donate blood to to further study covalescent plasma as a therapeutic.

My question is simple: could lmnl have a role in this?

I don't know the company very well and all this board seems to rant about is how TV is robbing retail investors.

Stay safe and all the best,

-69

179

Comment

Comment by PLITheOne on Apr 30, 2020 2:13pm

Deffinetly good advice to stay away from this company while they are winding down to nothing. Liminal gave away any opertunity to be effective in a Covid19 solution when they sold that division to KKR. This is smoke and mirrors now to hide their true intentions after stealling from their long term devoted shareholders. All we have now is ignorant, mindless, cheerleading going on by dispicable ...more

112

Comment

Comment by GunnerG on Apr 30, 2020 3:09pm

Newcamo group, did you just make a new ID?

109

Comment

Comment by foofadooo on Apr 30, 2020 11:25pm

These are the FDA requirements....... I believe we fit ..... Collection of COVID-19 Convalescent Plasma Health care providers or acute care facilities seeking to use COVID-19 convalescent plasma should include information in the IND submission that the COVID-19 convalescent plasma will be obtained from an FDA-registered blood establishment that follows the donor eligibility ...more

148

Comment

Comment by foofadooo on May 01, 2020 10:08am

Interesting read about Covid......bottom line is plasma certainly wouldn't be out of line for lung problems as a pre-treatment.....we never hear about that.... https://www.gatesnotes.com/Health/What-you-need-to-know-about-the-COVID-19-vaccine?WT.mc_id=20200430165003_COVID-19-vaccine_BG-TW@WT.tsrc=BGTW@linkId=87665522 foof

Comment

Comment by foofadooo on May 01, 2020 10:38am

This certainly shouldn't be overlooked by FDA or Clinics at this stage .... https://www.prnewswire.com/news-releases/prometic-presents-new-pbi-4050-and-ryplazim-plasminogen-data-on-lung-fibrosis-at-the-2019-ats-conference-300855067.html foof

131

Comment

Comment by GoBBs on May 01, 2020 12:21pm

Of course that would mean making actual progress which I'm starting to really doubt is their plan any longer ...

Comment

Comment by GunnerG on May 01, 2020 1:54pm

A poster presentation from last year where the two scientists have moved on. Same old pumpers.

Comment

Comment by GunnerG on May 01, 2020 4:24pm

I heard FDA had the poster presentation on their list of things to look at; number 56,941. Great volume again, those majors Newcamo and all his ID's keep talking must be snapping up everthing. 1,743 on the TSX.

Comment